ThromboGenics Announces that the FDA Intends to Grant Ocriplasmin Priority Review
From ThromboGenics NV
ThromboGenics NV announced that the FDA intends to grant its recently-submitted ocriplasmin BLA (Biological License Application) for priority review. The FDA grants priority review designation to drugs that may offer major advances in treatment, or provide a treatment where no adequate therapy exists. The FDA has a goal of completing a priority rev...
Login to read story
Friday, February 03, 2012
Allergan Expands Dry Eye Portfolio with Launch of Refresh Op...
From Allergan Inc. — 2/3/2012
Allergan, Inc. announced the launch of Refresh Optive Advanced, a new over-the-counter artificial tear option for patients suffering from dry eye symp...Full story
Majority of Americans Think Ideology Will Affect High Court'...
From Medscape Ophthalmology — 2/3/2012
With the Supreme Court just two months away from hearing a historic legal challenge to the 2010 health law, nearly 60 percent of the public ...Full story
Teledyne Awarded Laser Eye Protection Contract
From Teledyne Technologies Inc. — 2/3/2012
Teledyne Technologies Inc. announced that its subsidiary, Teledyne Scientific & Imaging, LLC (TS&I), was awarded a $7.7 million contract by th...Full story
Woman, 109, is the Oldest to Have a Cataract Surgery
From ShanghaiDaily.com — 2/3/2012
A 109-year-old woman received a cataract surgery in a Shanghai hospital today, making her the oldest person in China to have such a surgery. Guo Lians...Full story
Allergan 4th-Quarter Profit, Eye Drug Sales Rise
From Reuters — 2/3/2012
Allergan Inc. said on Thursday its fourth-quarter earnings rose 6.4 percent, as higher sales of its eye drugs, Lumigan and Restasis, offset lower-than...Full story
Thursday, February 02, 2012
FocalCenter Announces Development of EyecareScore
From FocalCenter — 2/2/2012
FocalCenter, a solution provider in eyecare patient experience metrics, announced completion of its validated and standardized EyecareScore surv...Full story
Vision and Hearing Loss in Older Adults May Coexist
From Medscape Today — 2/2/2012
Older adults who have trouble seeing low-contrast images may also be hampered by moderate bilateral hearing loss, contend vision researchers in the Ja...Full story
StemCells, Inc. Receives FDA Authorization for Age-Related M...
From StemCells, Inc. — 2/2/2012
StemCells, Inc. announced that the U.S. Food and Drug Administration has authorized the initiation of a Phase 1/2 clinical trial of the company's prop...Full story
Enrollment Up, Premiums Down in Medicare Advantage Plans
From Medpage Today — 2/2/2012
Enrollment in Medicare Advantage plans has risen by 10% in the past year and premiums have dropped by 7%, despite billions of dollars in reimbursement...Full story
First Vitus Femtosecond Laser Cataract Surgery Machine Launc...
From Pharmabiz.com — 2/2/2012
The worlds first Victus femtosecond laser cataract surgery machine was inaugurated by Dr. A. P. J. Abdul Kalam, former President of India, at Maxivisi...Full story
Wednesday, February 01, 2012
Celebrating 50 Years of Breakthroughs: Bascom Palmer Eye Ins...
From Bascom Palmer Eye Institute — 2/1/2012
Celebrating a half century of ophthalmic breakthroughs, Bascom Palmer Eye Institute of the University of Miami Miller School of Medicine is building o...Full story
Nextech Donates EMR to Tilganga Institute of Ophthalmology o...
From NexTech Systems, Inc — 2/1/2012
NexTech was honored to partake in a recent medical mission trip to Nepal alongside a team from The London Vision Clinic. The London Vision Clinic intr...Full story
Smartphone making your eyes tired?
From Medicine World — 2/1/2012
Several reports indicate that prolonged viewing of mobile devices and other stereo 3D devices leads to visual discomfort, fatigue and even headaches. ...Full story
RegeneRx Engages Investment Bankers to Assist in Evaluating ...
From RegeneRx Biopharmaceuticals, Inc. — 2/1/2012
RegeneRx Biopharmaceuticals, Inc. has hired investment bankers, Ameritech Advisors, LLC and Aurora Capital, LLC, to help the company evaluate and expl...Full story
Tearscience Achieves FDA Clearance for Second Generation Lip...
From TearScience, Inc. — 2/1/2012
TearScience, Inc. announced that it has received FDA clearance for its next generation product of its LipiFlow Thermal Pulsation System, a medical dev...Full story
Tuesday, January 31, 2012
Ruth D. Williams, MD, Begins Term as President of the Americ...
From American Academy of Ophthalmology — 1/31/2012
Ruth D. Williams, MD, a nationally-recognized medical leader, began her term as the 115th president of the American Academy of Ophthalmology earlier t...Full story
Ophthalmic Laser Market Set for Continued Growth
From Optics.org — 1/31/2012
An aging world population ensures that the number of patients needing vision correction procedures of all kinds will grow exponentially over the comin...Full story
Avedro Announces Canadian Approval for Lasik Xtra
From Avedro Inc. — 1/31/2012
Avedro, Inc. announced that the companys proprietary Lasik Xtra procedure has received Canadian approval. Lasik Xtra is a 2-minute procedure used in c...Full story
VGX-100 Identified as Potential New Therapy for Improving Co...
From Circadian Technologies Limited — 1/31/2012
Circadian Technologies Limited announced the publication of data in the scientific journal, Investigative Ophthalmology & Visual Science, showing ...Full story
Monday, January 30, 2012
Study: Eyes Windows To The Mind
From Medical News Today — 1/30/2012
The eyes are the window into the soul - or at least the mind, according to a new paper published in Perspectives on Psychological Science, a journal o...Full story
AAO and ASCRS Issue Medicare-Billing Guidance for Technology...
From EyewireToday.com — 1/30/2012
The two largest ophthalmic medical associations have partnered to release guidelines they say will assist ophthalmologists in determining their abilit...Full story
Valeant Withdraws Offer to Buy Ista Pharmaceuticals
From Bloomberg — 1/30/2012
Valeant Pharmaceuticals International Inc., Canadas biggest drugmaker, said it withdrew its $7.50 per share offer to buy Ista Pharmaceuticals Inc., ci...Full story
StemCells, Inc. Announces Publication of Preclinical Data De...
From StemCells, Inc. — 1/30/2012
StemCells, Inc. announced the publication of preclinical data demonstrating that its proprietary HuCNS-SC(R) cells (purified human neural stem cells) ...Full story
RP-US Military Launches 'Operation Cataract' in Zambo
From Zamboanga Today — 1/30/2012
The Western Mindanao Command (Wesmincom) and Joint Special Operations Task Force-Philippines (JSOTF-P) in coordination with Tzu Chi Foundation have la...Full story
Advertisement
- Glaucoma Specialist/ Catarat Surgeon
CT (Statewide)
Glaucoma Specialist/Cataract Surgeon, ConnecticutBeautiful office in the middle of a suburban town center that provides complete medical and surgical eye care for the entire family. Practice sees 25,000 patients per year...
- Ophthalmology Update 2012: New Approaches to Medical and Surgical Therapies
Friday, February 17, 2012
Omni San Diego Hotel
675 L Street
San Diego, CA 92101
